Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of SBIR/STTR awards granted to Neurocrine Biosciences

where

SBIR/STTR Award Recipient

Neurocrine Biosciences

Name	Description	SBIR/STTR Award Recipient	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Official Website
‌ Neurocrine Biosciences, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Neurocrine Biosciences for $133,540.0 USD from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR	1R43MH065106-01	Phase I	133,540	sbir.gov/content/crf-type-2-receptor-antagonists-anxiety-0
‌ Neurocrine Biosciences, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Neurocrine Biosciences for $139,497.0 USD from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR	1R43DK061863-01	Phase I	139,497	sbir.gov/content/selective-crf-antagonists-bowel-disorders-0
‌ Neurocrine Biosciences, Inc. STTR Phase I Award,	A STTR Phase I contract was awarded to Neurocrine Biosciences for $117,853.0 USD from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	STTR	PHS2001-2	Phase I	117,853	sbir.gov/content/hypocretins-and-their-role-control-sleep-0
‌ Neurocrine Biosciences, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Neurocrine Biosciences for $130,048.0 USD from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR	1R43AR047739-01A1	Phase I	130,048	sbir.gov/content/novel-crf-antagonists-inflammation-and-pain-0
‌ Neurocrine Biosciences, Inc. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Neurocrine Biosciences for $1,527,446.0 USD from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR	2R44GM061491-02	Phase II	1,527,446	sbir.gov/content/screening-library-peptide-activated-gpcrs-0
‌ Neurocrine Biosciences, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Neurocrine Biosciences for $139,336.0 USD from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR	1R43DK061159-01	Phase I	139,336	sbir.gov/content/novel-non-peptide-agonists-melanocortin-receptor-0
‌ Neurocrine Biosciences, Inc. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Neurocrine Biosciences for $946,531.0 USD from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR	2R44DK059107-02	Phase II	946,531	sbir.gov/content/novel-non-peptide-antagonist-mch-receptor-4
‌ Neurocrine Biosciences, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Neurocrine Biosciences for $136,412.0 USD from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR	1R43NS048676-01A1	Phase I	136,412	sbir.gov/content/brain-penetrating-h-3-receptor-agonists-insomnia-0
‌ Neurocrine Biosciences, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Neurocrine Biosciences for $170,479.0 USD from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR	1R43MH065720-01	Phase I	170,479	sbir.gov/content/corticotropin-releasing-factor-receptor-function-cns-0
‌ Neurocrine Biosciences, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Neurocrine Biosciences for $137,959.0 USD from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR	1R43NS041147-01A1	Phase I	137,959	sbir.gov/content/nonpeptide-antagonists-ccr-7-immunosuppression-0
‌ Neurocrine Biosciences, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Neurocrine Biosciences from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR	2R44GM061491-02	Phase I	0	sbir.gov/content/screening-library-peptide-activated-gpcrs-2
‌ Neurocrine Biosciences, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Neurocrine Biosciences from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR	2R44DK059107-02	Phase I	0	sbir.gov/content/novel-non-peptide-antagonist-mch-receptor-2
‌ Neurocrine Biosciences, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Neurocrine Biosciences for $99,390.0 USD from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR		Phase I	99,390	sbir.gov/content/not-available-9257
‌ Neurocrine Biosciences, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Neurocrine Biosciences for $99,931.0 USD from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR		Phase I	99,931	sbir.gov/content/not-available-9259
‌ Neurocrine Biosciences, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Neurocrine Biosciences from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR		Phase I	0	sbir.gov/content/not-available-9253
‌ Neurocrine Biosciences, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Neurocrine Biosciences for $240,527.0 USD from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR		Phase I	240,527	sbir.gov/content/not-available-9263
‌ Neurocrine Biosciences, Inc. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Neurocrine Biosciences for $635,649.0 USD from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR		Phase II	635,649	sbir.gov/content/not-available-9255
‌ Neurocrine Biosciences, Inc. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Neurocrine Biosciences for $471,580.0 USD from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR		Phase II	471,580	sbir.gov/content/novel-non-peptide-antagonists-gnrh-receptor-0
‌ Neurocrine Biosciences, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Neurocrine Biosciences for $207,018.0 USD from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR		Phase I	207,018	sbir.gov/content/melanocortin-4-receptor-antagonists-0
‌ Neurocrine Biosciences, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Neurocrine Biosciences for $138,733.0 USD from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR		Phase I	138,733	sbir.gov/content/novel-non-peptide-antagonist-mch-receptor-0
‌ Neurocrine Biosciences, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Neurocrine Biosciences for $133,067.0 USD from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR		Phase I	133,067	sbir.gov/content/not-available-9261
‌ Neurocrine Biosciences, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Neurocrine Biosciences from the U.S. Department of Health & Human Services.	Neurocrine Biosciences	SBIR		Phase I	0	sbir.gov/content/novel-non-peptide-antagonists-gnrh-receptor-2

22 results

0 selected

22 results

0 selected